Exelixis Future Growth
Future criteria checks 4/6
Exelixis is forecast to grow earnings and revenue by 32.3% and 10.9% per annum respectively. EPS is expected to grow by 29.2% per annum. Return on equity is forecast to be 17.5% in 3 years.
Key information
32.3%
Earnings growth rate
29.2%
EPS growth rate
Biotechs earnings growth | 30.9% |
Revenue growth rate | 10.9% |
Future return on equity | 17.5% |
Analyst coverage | Good |
Last updated | n/a |
Recent future growth updates
Recent updates
Earnings and Revenue Growth Forecasts
Date | Revenue | Earnings | Free Cash Flow | Cash from Op | Avg. No. Analysts |
---|---|---|---|---|---|
12/31/2024 | 2,052 | 392 | 586 | 555 | 11 |
12/31/2023 | 1,830 | 310 | 440 | 476 | 16 |
12/31/2022 | 1,602 | 171 | 202 | 181 | 15 |
9/30/2022 | 1,638 | 308 | 343 | 385 | N/A |
6/30/2022 | 1,555 | 273 | 310 | 359 | N/A |
3/31/2022 | 1,521 | 298 | 453 | 509 | N/A |
12/31/2021 | 1,435 | 231 | 337 | 401 | N/A |
9/30/2021 | 1,254 | 164 | 275 | 338 | N/A |
6/30/2021 | 1,157 | 94 | 218 | 272 | N/A |
3/31/2021 | 1,031 | 65 | 152 | 192 | N/A |
12/31/2020 | 988 | 112 | 179 | 209 | N/A |
9/30/2020 | 958 | 152 | 310 | 334 | N/A |
6/30/2020 | 998 | 282 | 372 | 391 | N/A |
3/31/2020 | 979 | 294 | 408 | 421 | N/A |
12/31/2019 | 968 | 321 | 514 | 527 | N/A |
9/30/2019 | 956 | 612 | 465 | 474 | N/A |
6/30/2019 | 910 | 642 | 541 | 563 | N/A |
3/31/2019 | 856 | 650 | 473 | 506 | N/A |
12/31/2018 | 854 | 690 | 382 | 416 | N/A |
9/30/2018 | 745 | 368 | 316 | 364 | N/A |
6/30/2018 | 672 | 323 | 203 | 237 | N/A |
3/31/2018 | 585 | 253 | 145 | 169 | N/A |
12/31/2017 | 452 | 154 | 144 | 166 | N/A |
9/30/2017 | 410 | 150 | 193 | 197 | N/A |
6/30/2017 | 320 | 58 | 151 | 154 | N/A |
3/31/2017 | 257 | 6 | 121 | 122 | N/A |
12/31/2016 | 191 | -70 | 209 | 210 | N/A |
9/30/2016 | 124 | -147 | 88 | 90 | N/A |
6/30/2016 | 71 | -181 | N/A | 61 | N/A |
3/31/2016 | 43 | -186 | N/A | 60 | N/A |
12/31/2015 | 37 | -162 | N/A | -141 | N/A |
Analyst Future Growth Forecasts
Earnings vs Savings Rate: EX9's forecast earnings growth (32.3% per year) is above the savings rate (0.03%).
Earnings vs Market: EX9's earnings (32.3% per year) are forecast to grow faster than the German market (14.5% per year).
High Growth Earnings: EX9's earnings are expected to grow significantly over the next 3 years.
Revenue vs Market: EX9's revenue (10.9% per year) is forecast to grow faster than the German market (4.6% per year).
High Growth Revenue: EX9's revenue (10.9% per year) is forecast to grow slower than 20% per year.
Earnings per Share Growth Forecasts
Future Return on Equity
Future ROE: EX9's Return on Equity is forecast to be low in 3 years time (17.5%).